Tianda Pharmaceuticals Ltd 2023 SR
The report highlights Tianda Pharmaceuticals' commitment to sustainability through its 'Tianda for health!' mission. In 2023, the company focused on community health initiatives, including free TCM consultations and the 'Little Chinese Physicians' program. Environmental efforts included managing emissions from its two manufacturing subsidiaries in Zhuhai and Yunnan, with a focus on wastewater treatment and energy efficiency. The Group also identified climate-related risks and set targets to reduce GHG emissions, energy, and water consumption by 3% by 2028. Notable recognitions included the 'Most Valuable Pharmaceutical and Medical Company' award.
Company: Tianda Pharmaceuticals Ltd
Sector: Health Care
Country: Hong Kong
Year: 2023
Type: SR
Pages: 32
Tianda Pharmaceuticals Ltd
ESG Report
The report highlights Tianda Pharmaceuticals' commitment to sustainability through its 'Tianda for health!' mission. In 2023, the company focused on community health initiatives, including free TCM consultations and the 'Little Chinese Physicians' program. Environmental efforts included managing emissions from its two manufacturing subsidiaries in Zhuhai and Yunnan, with a focus on wastewater treatment and energy efficiency. The Group also identified climate-related risks and set targets to reduce GHG emissions, energy, and water consumption by 3% by 2028. Notable recognitions included the 'Most Valuable Pharmaceutical and Medical Company' award.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Apr 26, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Workplace Fatalities
Employees